Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association.
Prystowsky
E N
EN
American Heart Association, Dallas, TX 75231-4596, USA.
Benson
D W
DW
Fuster
V
V
Hart
R G
RG
Kay
G N
GN
Myerburg
R J
RJ
Naccarelli
G V
GV
Wyse
D G
DG
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D002561:Cerebrovascular Disorders / Q000517:prevention & control; D006439:Hemodynamics; D006801:Humans; D013923:Thromboembolism / Q000517:prevention & control
D000889:Anti-Arrhythmia Agents